NCT01431664View on ClinicalTrials.gov

AT9283 in Treating Young Patients With Relapsed or Refractory Acute Leukemia

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Leukemia
Interventions
DRUG

multikinase inhibitor AT9283

OTHER

laboratory biomarker analysis

OTHER

pharmacological study

Trial Locations (5)

SM2 5PT

Royal Marsden Hospital, Surrey

B4 6NH

Birmingham Children's Hospital, Birmingham

LS1 3EX

Leeds General Infirmary, Leeds

M13 9WL

Royal Manchester Children's Hospital, Manchester

NE1 4LP

Great North Children's Hospital, Royal Victoria Infirmary, Newcastle upon Tyne

Sponsors

Lead Sponsor

Cancer Research UK
All Listed Sponsors
lead

Cancer Research UK

OTHER